This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Overactive Bladder, Urinary Incontinence, Urinary Frequency or Urgency Adverse Event or Nocturia
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

This study aims to assess the efficacy of a specialized herbal formula, Urox, versus control over 8 weeks, in a double blind, placebo controlled trial. 150 participants are being recruited, randomized and administered treatment or placebo for the period of 8 weeks after initial eligibility screening. Outcome measures include previously validated tools such as the 3 day symptom diary measuring self-recorded day frequency, nocturia, urgency and incontinence episodes. Quality of life improvements are being measured using the Incontinence Impact Questionnaire, Urinary Distress Inventory and the short version of the OverActive Bladder survey.

Provided treatments

  • : Urox
  • Other: Placebo
Tris trial is registered with FDA with number: NCT02396160. The sponsor of the trial is The University of Queensland and it is looking for 150 volunteers for the current phase.
Official trial title:
The Effect of Urox™(Crateva, Horsetail and Lindera Combination) in the Treatment of Overactive Bladder and Urinary Incontinence